Kolmar Korea Co., Ltd.

KSE 161890.KS

Kolmar Korea Co., Ltd. EBIT for the year ending December 31, 2023: USD 58.43 M

Kolmar Korea Co., Ltd. EBIT is USD 58.43 M for the year ending December 31, 2023, a 45.46% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Kolmar Korea Co., Ltd. EBIT for the year ending December 31, 2022 was USD 40.17 M, a -51.04% change year over year.
Kolmar Korea Co., Ltd. EBIT for the year ending December 31, 2021 was USD 82.05 M, a -65.48% change year over year.
Kolmar Korea Co., Ltd. EBIT for the year ending December 31, 2020 was USD 237.68 M, a 179.51% change year over year.
Kolmar Korea Co., Ltd. EBIT for the year ending December 31, 2019 was USD 85.04 M, a 7.11% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

KSE: 161890.KS

Kolmar Korea Co., Ltd.

CEO	Mr. Hyun-Gyu Choi
IPO Date	Oct. 18, 2012
Location	South Korea
Headquarters	12-11 Doekgogae-gil
Employees	1,152
Sector	Consumer Discretionary
Industries Cosmetics Dental Care Drugstores & Retail Pharmacies Personal Care Pharmaceuticals

Description

Kolmar Korea Co., Ltd. researches, develops, produces, and sells beauty and health products in South Korea and internationally. It offers various cosmetic products, including skin care, makeup, baby, hair care, and body care products, as well as perfume, functional cosmetics, and qusi drugs. The company also provides prescription, over-the-counter, and bioequivalent drugs; drugs for dermatology and circulatory system; ointment and external, and oral solutions; and oral solids. In addition, it offers health functional food comprising health supplements; ingredients; special purpose food; and individually recognized health supplements. The company was founded in 2012 and is headquartered in Sejong, South Korea.

Key trends

Past 5 years